文献速递肝病消化道肿瘤与早癌

IL-1β诱导SLC7A11升高通过上调PD-L1和CSF1促进肝细胞癌转移

IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1.
PubMed 文献 · Hepatology · 2021-08-27

该研究探讨炎症相关肝细胞癌(HCC)转移机制,发现IL-1β通过IL-1R1/ERK/SP1通路上调SLC7A11,SLC7A11经αKG-HIF1α轴增加PD-L1和CSF1表达,促进肿瘤相关巨噬细胞和髓系抑制细胞浸润及HCC转移。联合CSF1R抑制剂BZL945与抗PD-L1抗体或IL-1R1拮抗剂Anakinra可阻断该转移过程。

要点

  • SLC7A11高表达与HCC低分化、高TNM分期及不良预后正相关。
  • IL-1β通过IL-1R1/ERK/SP1通路上调SLC7A11,进而经αKG-HIF1α轴促进PD-L1和CSF1表达。
  • CSF1R抑制剂BZL945联合抗PD-L1抗体或Anakinra可阻断SLC7A11介导的HCC转移。

核心结论

  • IL-1β诱导的SLC7A11过表达通过αKG/HIF1α轴上调PD-L1和CSF1,促进TAM和MDSC浸润及HCC转移;干预该环路可能成为抑制SLC7A11介导HCC转移的治疗策略。

研究设计与样本

  • 基础与转化研究,涉及人HCC组织分析及HCC细胞与小鼠模型实验,具体样本量未报告。

主要发现

  • SLC7A11高表达与HCC低分化、高TNM分期和不良预后正相关。
  • SLC7A11通过减少αKG水平增加HIF1α表达,进而上调PD-L1和CSF1。
  • SLC7A11过表达通过CSF1/CSF1R轴促进瘤内TAM和MDSC浸润,敲低CSF1可减弱该浸润及HCC转移。
  • 清除TAM或MDSC均减少SLC7A11介导的HCC转移。
  • IL-1β通过IL-1R1/ERK/SP1通路上调SLC7A11,敲低SLC7A11或使用Anakinra可逆转IL-1β促进的HCC转移。

关键数值与推荐

  • 联合CSF1R抑制剂BZL945与抗PD-L1抗体可阻断SLC7A11诱导的HCC转移。
  • IL-1R1拮抗剂Anakinra可逆转IL-1β促进的HCC转移。
  • 人HCC组织中SLC7A11表达与HIF1α、PD-L1、CSF1表达及瘤内TAM和MDSC浸润正相关。

临床怎么用

  • 对于SLC7A11高表达或IL-1β驱动的HCC亚群,可考虑靶向CSF1R/PD-L1轴或使用IL-1R1拮抗剂Anakinra抑制转移。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Because of a paucity of effective treatment options, metastasis is still a major cause for HCC-associated mortality. The molecular mechanism of inflammation-induced HCC metastasis is open for study. Here, we characterized the function of solute carrier family 7 member 11 (SLC7A11) in inflammation-related HCC metastasis and probed therapy strategies for this subpopulation of patients. APPROACH AND RESULTS: Elevated expression of SLC7A11 was positively correlated with poor tumor differentiation, and higher tumor-nodule-metastasis stage, and indicated poor prognosis in human HCC. SLC7A11 increased HIF1α expression through reducing α-ketoglutarate (αKG) level by exporting glutamate. SLC7A11 up-regulated programmed death ligand 1 (PD-L1) and colony-stimulating factor 1 (CSF1) expression through αKG-HIF1α cascade. SLC7A11 overexpression in HCC cells promoted intratumoral tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) infiltration through the CSF1/colony-stimulating factor 1 receptor (CSF1R) axis, whereas knockdown of CSF1 attenuated SLC7A11-mediated intratumoral TAM and MDSC infiltration and HCC metastasis. Depletion of either TAMs or MDSCs decreased SLC7A11-mediated HCC metastasis. Furthermore, the combination of CSF1R inhibitor BZL945 and anti-PD-L1 antibody blocked SLC7A11-induced HCC metastasis. In addition, IL-1β up-regulated SLC7A11 expression through the interleukin-1 receptor type 1 (IL-1R1)/extracellular signal-regulated kinase/specificity protein 1 pathway. SLC7A11 knockdown impaired IL-1β-promoted HCC metastasis. Anakinra, an IL-1R1 antagonist, reversed IL-1β-promoted HCC metastasis. In human HCC tissues, SLC7A11 expression was positively associated with HIF1α, PD-L1, and CSF1 expression and intratumoral TAM and MDSC infiltration. CONCLUSIONS: IL-1β-induced SLC7A11 overexpression up-regulated PD-L1 and CSF1 through the αKG/HIF1α axis, which promoted TAM and MDSC infiltration. Interruption of this oncogenic loop may provide a promising therapy strategy for the inhibition of SLC7A11-mediated HCC metastasis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. He Q, Liu M, Huang W, et al. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. Hepatology. 2021. PMID: 34288020. doi:10.1002/hep.32062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。